1. Medibeacon Inc. (21 from 58 patents)

2. Pharmacia Corporation (14 from 200 patents)

3. Mallinckrodt Medical, Inc. (6 from 181 patents)

4. Mallinckrodt, Inc. (4 from 717 patents)

5. Medibeacon Development LLC (3 from 3 patents)

6. Monsanto Company (2 from 3,288 patents)

7. Washington University (2 from 1,579 patents)

8. The Texas A&m University System (2 from 1,238 patents)

9. Southern Illinois University (2 from 110 patents)

10. Other (1 from 832,680 patents)

11. Warner-lambert Company (1 from 2,538 patents)

12. Galera Labs, LLC (1 from 22 patents)

13. Galera Therapeutics, LLC (1 from 5 patents)

14. Metaphore Pharmaceuticals, Inc. (1 from 1 patent)

1. 11912687 - 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof

2. 11602570 - Compositions and systems for renal function determination

3. 11590244 - Methods for renal function determination

4. 11136312 - 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof

5. 10967096 - Tissue sealant compositions, vascular closure devices, and uses thereof

6. 10960104 - Tissue sealant compositions, vascular closure devices, and uses thereof

7. 10881759 - Tissue sealant compositions, vascular closure devices, and uses thereof

8. 10617687 - Fluorescent pyrazine derivatives and methods of using the same in assessing renal function

9. 10370362 - Pyrazine derivatives with extended conjugation and methods of using the same in optical applications

10. RE47413 - Pyrazine derivatives and uses thereof in renal monitoring

11. RE47255 - Pyrazine derivatives and uses thereof in renal monitoring

12. 9662387 - Functional, cross-linked nanostructures for tandem optical imaging and therapy

13. 9480687 - Pyrazine derivatives and uses thereof in renal monitoring

14. 9433700 - Tissue sealant compositions, vascular closure devices, and uses thereof

15. 9376399 - Fluorescent pyrazine derivatives and methods of using the same in assessing renal function